This is supported by the finding that SARS-CoV-2 cross-reactive CD8+ T cells were increased in CMV-seropositive (CMV+) donors and that previous CMV infection has been associated with severe COVID-19 (Alanio et al., 2022; Jo et al., 2021; Weber et al., 2022). The gene discussed is CD8A; the disease is COVID-19.